Technology transfer within major pharma
The client was a major pharma that acquired outside technology targeted at
an enterprise-critical production process. ZeeForge was retained to assess the
applied functionality of the new technology, explore issues related to its use,
and determine the best business alternatives for future support of the technology
and process. After consultation with the client, ZeeForge was tasked to answer
two questions: (1) How well is the new technology supporting the work of the critical
process and (2) What, if anything, should be done to address any issues or pitfalls
discovered about the performance and use of the technology?
ZeeForge is eager to share
more information about this example. We are still preparing that information
for publication. Please use the form below to request our pre-publication
material.